| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arthritis, Rheumatoid | D001172 | 3 associated lipids |
| Liver Diseases | D008107 | 31 associated lipids |
| Occupational Diseases | D009784 | 42 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Leukemia P388 | D007941 | 43 associated lipids |
| Chemical and Drug Induced Liver Injury | D056486 | 39 associated lipids |
| Hypertension, Pulmonary | D006976 | 32 associated lipids |
| Myocardial Infarction | D009203 | 21 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Smith AA et al. | The CanOE strategy: integrating genomic and metabolic contexts across multiple prokaryote genomes to find candidate genes for orphan enzymes. | 2012 | PLoS Comput. Biol. | pmid:22693442 |
| Chaudhuri RR et al. | Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. | 2010 | PLoS ONE | pmid:20098708 |
| Bidossi A et al. | A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae. | 2012 | PLoS ONE | pmid:22428019 |
| Galindo P et al. | Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation. | 2012 | PLoS ONE | pmid:22427863 |
| Barbieri C et al. | Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients. | 2016 | PLoS ONE | pmid:26939055 |
| Connor JR et al. | Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations. | 2015 | PLoS ONE | pmid:25973894 |
| Italia K et al. | Hydroxyurea could be a good clinically relevant iron chelator. | 2013 | PLoS ONE | pmid:24349400 |
| Ruiz JC et al. | Evidence for reductive genome evolution and lateral acquisition of virulence functions in two Corynebacterium pseudotuberculosis strains. | 2011 | PLoS ONE | pmid:21533164 |
| Drzewiecki J | Excretion of D-glucaric acid and metabolism of salicylamide in man: the effect of phenobarbital-produced enzymatic induction. | 1977 Jul-Aug | Pol J Pharmacol Pharm | pmid:905203 |
| Horváth T et al. | Investigation of biotransformation capacity in patients with chronic liver diseases by pharmacokinetic methods: experimental trials. | 1984 Jul-Aug | Pol J Pharmacol Pharm | pmid:6396596 |
| Grzegorzewska AE | [Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease]. | 2007 | Pol. Arch. Med. Wewn. | pmid:17722476 |
| Zółtaszek R et al. | [The biological role of D-glucaric acid and its derivatives: potential use in medicine]. | 2008 | Postepy Hig Med Dosw (Online) | pmid:18772850 |
| Murchison LE et al. | Effects of anticonvulsants and inactivity on bone disease in epileptics. | 1975 | Postgrad Med J | pmid:1161672 |
| Cynke E | [Parenteral iron replacement]. | 1997 | Praxis (Bern 1994) | pmid:9312810 |
| Ferumoxytol: an intravenous iron, riskier than iron sucrose. | 2013 | Prescrire Int | pmid:24171212 | |
| Raman S et al. | Evolution-guided optimization of biosynthetic pathways. | 2014 | Proc. Natl. Acad. Sci. U.S.A. | pmid:25453111 |
| Abou-Issa HM et al. | Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene. | 1988 | Proc. Natl. Acad. Sci. U.S.A. | pmid:2967969 |
| Florey L | The uptake of particulate matter by endothelial cells. | 1967 | Proc. R. Soc. Lond., B, Biol. Sci. | pmid:24796034 |
| Fujihira E and Whitehouse MW | Pathobiodynamics: reduced ascorbate excretion by rats with severe inflammation. | 1977 | Proc. Soc. Exp. Biol. Med. | pmid:877135 |
| Soldato PD and Meli A | Studies on the mechanism of fat-free diet (FFD) protection against indomethacin-induced intestinal ulcers. | 1978 | Proc. Soc. Exp. Biol. Med. | pmid:662870 |
| Pach J et al. | New possibilities in scintigraphy detection of carbon monoxide cardiotoxicity. | 2001 | Prz. Lek. | pmid:11450331 |
| Beck IA | Serendipity lost: a digressive account of an experience in the investigation of glucoronic acid metabolism in diabetes mellitus. | 1991 | R I Med J | pmid:2047701 |
| Park BK et al. | [Modification of the action of drugs by inhibition of their metabolism]. | 1979 | Recenti Prog Med | pmid:42953 |
| Toyokuni S | Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. | 2014 | Redox Rep. | pmid:24257681 |
| Borchard G et al. | Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies. | 2012 | Regul. Toxicol. Pharmacol. | pmid:22951348 |
| Harmankaya O and Eran A | Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin. | 2002 | Ren Fail | pmid:12071600 |
| Ozkurt S et al. | Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients. | 2012 | Ren Fail | pmid:22017464 |
| Solak Y et al. | Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients. | 2011 | Ren Fail | pmid:21401355 |
| Anirban G et al. | The comparative safety of various intravenous iron preparations in chronic kidney disease patients. | 2008 | Ren Fail | pmid:18661414 |
| Sav T et al. | Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? | 2007 | Ren Fail | pmid:17497463 |
| Guz G et al. | Elevated cardiac troponin T in hemodialysis patients receiving more intravenous iron sucrose. | 2004 | Ren Fail | pmid:15600258 |
| Oredipe OA et al. | Chemopreventative activity of dietary glucarate on azoxymethane-induced altered hepatic foci in rats. | 1989 | Res. Commun. Chem. Pathol. Pharmacol. | pmid:2479062 |
| Mezey E | Increased urinary excretion of D-glucaric acid in alcoholism. | 1976 | Res. Commun. Chem. Pathol. Pharmacol. | pmid:1005917 |
| Cançado RD et al. | [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia]. | 2005 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:16444338 |
| Gredilla E et al. | [Treating severe acute anemia due to vaginal bleeding in the Jehovah's Witness: a report of 2 cases]. | 2009 | Rev Esp Anestesiol Reanim | pmid:20151526 |
| Escartin Marin P et al. | [Enzyme induction in alcoholic and cryptogenetic cirrhoses]. | 1976 | Rev Esp Enferm Apar Dig | pmid:1257561 |
| Chailleux E et al. | [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment]. | 1980 | Rev Fr Mal Respir | pmid:7187065 |
| Tutor-Crespo MJ et al. | [A study of some indirect biochemical markers in the evaluation of enzymatic induction caused by antiepileptic drugs]. | 2002 Oct 16-31 | Rev Neurol | pmid:12402220 |
| Smirne S et al. | [Serum gamma-glutamyl-transpeptidase and urinary excretion of D-glucaric acid in epileptic patients treated with anticonvulsants]. | 1974 Jul-Aug | Riv Neurol | pmid:4155805 |
| Bergonzi P et al. | [Long-term anticonvulsant therapy and calcium and phosphorus metabolism]. | 1979 Jan-Feb | Riv Neurol | pmid:451400 |
| Souqiyyeh MZ and Shaheen FA | Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. | 2003 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18209438 |
| Zolezzi M | Intravenous Iron Saccharate Complex: Guidelines for its use in the Management of Anemia of Renal Disease. | 2003 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18209437 |
| Al-Mueilo SH | Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients. | 2005 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18202490 |
| Shaheen FA et al. | Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients. | 2002 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:17660651 |
| Swarnalatha G et al. | Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress. | 2010 | Saudi J Kidney Dis Transpl | pmid:20814119 |
| Haddad A et al. | Use of iron sucrose in dialysis patients sensitive to iron dextran. | 2009 | Saudi J Kidney Dis Transpl | pmid:19237805 |
| Gupta A et al. | Response to iron sucrose in dialysis patients sensitive to iron dextran. | 2010 | Saudi J Kidney Dis Transpl | pmid:20587886 |
| Hotz P et al. | Study of some hepatic effects (induction and toxicity) caused by occupational exposure to styrene in the polyester industry. | 1980 | Scand J Work Environ Health | pmid:6937826 |
| Sandstad O et al. | Urinary D-glucaric acid, a marker substance for microsomal enzyme induction. Methodological aspects, responses to alcohol and findings in workers exposed to toluene. | 1993 | Scand. J. Clin. Lab. Invest. | pmid:8378735 |
| Erichsen K et al. | Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. | 2005 | Scand. J. Gastroenterol. | pmid:16165718 |